CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 97 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,508,213 | -37.3% | 69,089 | -8.8% | 0.00% | -33.3% |
| Q2 2023 | $2,407,266 | +29.4% | 75,724 | -0.7% | 0.00% | 0.0% |
| Q1 2023 | $1,859,640 | -23.5% | 76,246 | -1.1% | 0.00% | -25.0% |
| Q4 2022 | $2,431,198 | +18.7% | 77,083 | +6.3% | 0.00% | +33.3% |
| Q3 2022 | $2,049,000 | +5.5% | 72,499 | -1.4% | 0.00% | 0.0% |
| Q2 2022 | $1,943,000 | +0.3% | 73,498 | +32.8% | 0.00% | 0.0% |
| Q1 2022 | $1,938,000 | +1.3% | 55,347 | -6.2% | 0.00% | +50.0% |
| Q4 2021 | $1,913,000 | +14.8% | 58,999 | +4.5% | 0.00% | 0.0% |
| Q3 2021 | $1,666,000 | +33.7% | 56,480 | +16.1% | 0.00% | 0.0% |
| Q2 2021 | $1,246,000 | – | 48,634 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |